Mydecine Innovations Group Announces Filing of Provisional Patent for the Treatment of PTSD with Psilocybin

Mydecine Innovations Group Announces Filing of Provisional Patent for the Treatment of PTSD with Psilocybin

Press Release….VANCOUVER, British Columbia, Oct. 07, 2020 (GLOBE NEWSWIRE) — Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: NLBIF) (FSE:0NF) (“Mydecine” or the “Company”), is … Read More… The post Mydecine Innovations Group Announces Filing of Provisional Patent for the Treatment of PTSD with Psilocybin first appeared on Cannabis Law Report.

Excerpt only …
READ MORE BELOW
Source : CANNANNEW REPORT
Link to original : Mydecine Innovations Group Announces Filing of Provisional Patent for the Treatment of PTSD with Psilocybin
reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.